3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
3
Breast Neoplasms
2
Melanoma
1
Interventions
Radiosurgery
3
Radiotherapy
2
osimertinib
1
cemiplimab
1
aflutinib
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Drug Therapy
1
Docetaxel
1
Cryotherapy
1
Anterior Temporal Lobectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
NSCLC
×
famitinib
×
90 days
×
Clear all
No trials found.